Moderna Inc.
Company Snapshot
Founded: 2010
Entity Type: Public
Employees: 5,800
Region: U.S.
Revenue: $3,236.0 Millions
Revenue Year: 2024
Headquarter: Massachusetts, U.S.
Key Geographics: U.S., Europe
Corporate Address: 325 Binney Street Cambridge, Massachusetts 02142 U.S. Tel. +1-617-714-6500 www.modernatx.com
Company Overview
Moderna, Inc., is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. Moderna is a leader in messenger RNA (mRNA) medicine. Its COVID-19 vaccine brought it to the forefront during the COVID-19 pandemic.
The mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, rare diseases, oncology, and autoimmune diseases. Beyond COVID-19, the company is focusing on new therapeutics and vaccines. The company’s pipeline consists of 45 therapeutic and immunization programs.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Moderna Inc. In News
Applications/End User Industries
- mRNA
- Cardiovascular
- Autoimmune
- Healthcare
- Pharmaceutical
- Medical Researchers
- mRESVIA
- Immuno-Oncology
- Cancer Therapies
BCC Research Beacon 